About
Contact & Profiles
A5002874762
Research Areas
- Cancer-related Molecular Pathways
- Microtubule and mitosis dynamics
- Cancer Mechanisms and Therapy
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Chemical Synthesis and Analysis
- Nanoparticle-Based Drug Delivery
- Neuroblastoma Research and Treatments
- Therapeutic Uses of Natural Elements
- Cyclization and Aryne Chemistry
- Hepatocellular Carcinoma Treatment and Prognosis
- Myofascial pain diagnosis and treatment
- Lung Cancer Research Studies
- Gout, Hyperuricemia, Uric Acid
- Inflammasome and immune disorders
- Monoclonal and Polyclonal Antibodies Research
Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2024
Peking Union Medical College Hospital
2024
10.1016/j.lfs.2023.121941
article
EN
Life Sciences
2023-07-13
10.1016/j.ejphar.2022.174802
article
EN
European Journal of Pharmacology
2022-02-08
10.1016/j.jddst.2023.105101
article
EN
Journal of Drug Delivery Science and Technology
2023-10-29
10.1007/s10637-021-01210-6
article
EN
Investigational New Drugs
2022-01-12
<title>Abstract</title> Background Glypican-2 (GPC2), a member of the GPC gene family, primarily functions in developing neural and thyroid cancer tissues, exerting influence on protein transduction, cellular proliferation differentiation, as well oncogenic signatures. GPC2 exhibits significant overexpression majority neuroblastoma (NB) samples while remaining nearly undetectable normal pediatric tissue samples. Methods Overall survival (OS) was employed key parameter to investigate...
10.21203/rs.3.rs-5242931/v1
preprint
EN
cc-by
Research Square (Research Square)
2024-10-22
10.1016/j.jddst.2023.105213
article
EN
Journal of Drug Delivery Science and Technology
2023-11-29
10.11569/wcjd.v26.i5.349
article
EN
Shijie huaren xiaohua zazhi
2018-02-08
Coming Soon ...